• AAPL 167.04
  • TSLA 149.9
  • AMZN 179.17
  • MSFT 404.33
  • INTC 35.04
  • EURUSD 1.0676
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. PINK /
  3. AFFY.PINK

Affymax Inc. (AFFY PINK) stock market data APIs

$0.0007 0(0%) as of April 18, 2024

Affymax Inc. Financial Data Overview

0.0007
0.0007
-
0.0007
0.0007
0.0002-0.0044
2 441 K
0
37 490 K
42 000
0
6.042
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'AFFY',
Type: 'Common Stock',
Name: 'Affymax Inc.',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000DQRYV9',
ISIN: NULL,
CUSIP: NULL,
CIK: '1158223',
EmployerIdNumber: '77-0579396',
FiscalYearEnd: 'December',
IPODate: '2006-12-15',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Affymax Inc. Fundamental Data is available in our Financial Data APIs

  • Net Revenue 42 000
  • EBITDA -47 648 000
  • Earnings Per Share 0
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Affymax Inc. Earnings via APIs

  • Latest Release 2024-02-28
  • EPS/Forecast 0

Get Affymax Inc. End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Affymax Inc. latest news via APIs

89bio Announces Appointment of Kathy LaPorte to its Board of Directors

SAN FRANCISCO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for t...
  • 89BIO
  • DIRECTORS AND OFFICERS
  • INC
  • NASDAQ:ETNB

89bio Announces Appointment of Kathy LaPorte to its Board of Directors

SAN FRANCISCO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the...
  • 89BIO
  • BIOPHARMACEUTICAL COMPANY
  • BIOTECH INDUSTRY
  • BOARD EXPERIENCE
  • CHIEF EXECUTIVE OFFICER
  • INC
  • INNOVATIVE THERAPIES
  • KATHY LAPORTE
  • LAPORTE
  • NASDAQ
Do you have any questions?
support@eodhistoricaldata.com